173 related articles for article (PubMed ID: 12807231)
1. Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients.
Morice P; Rodriguez A; Rey A; Pautier P; Atallah D; Genestie C; Pomel C; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
Eur J Gynaecol Oncol; 2003; 24(3-4):237-40. PubMed ID: 12807231
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma.
Gao Z; Li L; Meng Y
PLoS One; 2016; 11(2):e0148050. PubMed ID: 26828206
[TBL] [Abstract][Full Text] [Related]
3. Impact of Surgery on the Evolution of Uterine Sarcomas.
Cusidó M; Fargas F; Baulies S; Plana A; Rodríguez I; Tresserra F; Pascual MA; Fábregas R
J Minim Invasive Gynecol; 2015; 22(6):1068-74. PubMed ID: 26070730
[TBL] [Abstract][Full Text] [Related]
4. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.
Xu X; Lin H; Wright JD; Gross CP; Boscoe FP; Hutchison LM; Schwartz PE; Desai VB
J Clin Oncol; 2019 Dec; 37(35):3412-3424. PubMed ID: 31518176
[TBL] [Abstract][Full Text] [Related]
5. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
6. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
Mowers EL; Skinner B; McLean K; Reynolds RK
J Minim Invasive Gynecol; 2015; 22(4):601-6. PubMed ID: 25596464
[TBL] [Abstract][Full Text] [Related]
7. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease.
Lee JY; Kim HS; Nam EJ; Kim SW; Kim S; Kim YT
BMC Cancer; 2016 Aug; 16(1):675. PubMed ID: 27553655
[TBL] [Abstract][Full Text] [Related]
9. Uterine morcellation and survival in uterine sarcomas.
Bretthauer M; Goderstad JM; Løberg M; Emilsson L; Ye W; Adami HO; Kalager M
Eur J Cancer; 2018 Sep; 101():62-68. PubMed ID: 30025231
[TBL] [Abstract][Full Text] [Related]
10. Sarcoma Risk in Uterine Surgery in a Tertiary University Hospital in Germany.
Kundu S; Zachen M; Hertel H; Hillemanns P; Soergel P
Int J Gynecol Cancer; 2017 Jun; 27(5):961-966. PubMed ID: 28498262
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
[TBL] [Abstract][Full Text] [Related]
12. Vaginal Morcellation Inside Protective Pouch: A Safe Strategy for Uterine Extration in Cases of Bulky Endometrial Cancers: Operative and Oncological Safety of the Method.
Favero G; Miglino G; Köhler C; Pfiffer T; Silva e Silva A; Ribeiro A; Le X; Anton C; Baracat EC; Carvalho JP
J Minim Invasive Gynecol; 2015; 22(6):938-43. PubMed ID: 25917277
[TBL] [Abstract][Full Text] [Related]
13. Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation.
Tan-Kim J; Hartzell KA; Reinsch CS; O'Day CH; Kennedy JS; Menefee SA; Harrison TA
Am J Obstet Gynecol; 2015 May; 212(5):594.e1-10. PubMed ID: 25499259
[TBL] [Abstract][Full Text] [Related]
14. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
15. Unsuspected Uterine Sarcoma in an Urban Hospital: Does Surgical Approach Matter?
DiNapoli MN; Truong MD; Halfon JK; Burke WM
J Minim Invasive Gynecol; 2018; 25(3):491-497. PubMed ID: 29061369
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease.
Von Bargen EC; Grimes CL; Mishra K; Wang R; Haviland MJ; Hacker MR; Carnevale JA; Estes AJ; Elkadry EA
Int J Gynaecol Obstet; 2017 May; 137(2):123-128. PubMed ID: 28170091
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Tissue Morcellation During Surgery for Uterine Sarcoma at a Canadian Academic Centre.
Chen I; Hopkins L; Firth B; Boucher J; Singh SS
J Obstet Gynaecol Can; 2015 May; 37(5):421-425. PubMed ID: 26168102
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
Wasson M; Magtibay P; Magtibay P; Magrina J
J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma.
Lin KH; Torng PL; Tsai KH; Shih HJ; Chen CL
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):172-7. PubMed ID: 25951723
[TBL] [Abstract][Full Text] [Related]
20. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
